Ekso Bionics approves 1-for-15 reverse stock split effective May 27, 2025 to regain Nasdaq compliance

EKSO BIONICS HOLDINGS, INC.

Reverse split ratio set at 1-for-15; effective 12:01 a.m. PT on May 27, 2025.
Post-split shares ~2.35M vs pre-split ~35.3M; par value unchanged at $0.001.
Stock will trade on Nasdaq (symbol EKSO) on split-adjusted basis; new CUSIP 282644400.
Fractional shares rounded up to next whole share; no proportional cut in authorized shares.
Purpose: raise per-share price to meet $1 minimum bid for 10 consecutive trading days.

item 5.07item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.